AR101589A1 - Derivados de iminonitrilo - Google Patents

Derivados de iminonitrilo

Info

Publication number
AR101589A1
AR101589A1 ARP150102666A ARP150102666A AR101589A1 AR 101589 A1 AR101589 A1 AR 101589A1 AR P150102666 A ARP150102666 A AR P150102666A AR P150102666 A ARP150102666 A AR P150102666A AR 101589 A1 AR101589 A1 AR 101589A1
Authority
AR
Argentina
Prior art keywords
alkyl
optionally substituted
mono
cyclic
aryl
Prior art date
Application number
ARP150102666A
Other languages
English (en)
Original Assignee
Curadev Pharma Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curadev Pharma Pvt Ltd filed Critical Curadev Pharma Pvt Ltd
Publication of AR101589A1 publication Critical patent/AR101589A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicación 1: Compuesto de fórmula (1), en la que: X¹ es CR¹, N o NO; X² es CR², N o NO; X³ es CR³, N o NO; X⁴ es CR⁴, N o NO, en la que por lo menos uno de entre X¹, X², X³ y X⁴ es N; R¹, R², R³ y R⁴ se seleccionan independientemente de entre el grupo que consiste de H, alquilo C₁₋₆ opcionalmente sustituido, alquenilo C₂₋₆ opcionalmente sustituido, alquinilo C₂₋₆ opcionalmente sustituido, alcoxi C₁₋₆ opcionalmente sustituido, arilo C₆₋₁₄ mono- o bi-cíclico opcionalmente sustituido, heteroarilo opcionalmente sustituido mono- o bi-cíclico, (aril)alquilo opcionalmente sustituido,(alcoxi)carbonilo, (alquil)amido, (alquil)amino, cicloalquilo mono- o bi-cíclico opcionalmente sustituido, heterociclilo mono- o bi-cíclico opcionalmente sustituido, amonialquilo, alquilcarboxilo, (alquil)carboxiamido, (aril)amino opcionalmente sustituido, hidroxilo, halógeno, haloalquilo C₁₋₆, heterociclil(alquilo)- opcionalmente sustituido, heteroaril(alquilo) opcionalmente sustituido, hidroxialquilo, perfluoroalquilo, ariloxi opcionalmente sustituido, heteroariloxi opcionalmente sustituido, cicloalcoxi C₃₋₈ opcionalmente sustituido, N(R⁵)₂, CN, NO₂, CO₂H, CONRARB, S(O)ₙR⁵ y heterocicliloxi opcionalmente sustituido que presenta 1 a 2 heteroátomos seleccionados de entre el grupo que consiste de O, S(O)ₙ y NR⁶; n es 0 a 2; RA y RB se seleccionan independientemente de entre el grupo que consiste de H, alquilo C₁₋₆ opcionalmente sustituido, arilo C₆₋₁₄ mono- o bi-cíclico opcionalmente sustituido, heteroarilo mono- o bi-cíclico opcionalmente sustituido, (aril)alquilo opcionalmente sustituido, cicloalquilo C₃₋₈ mono- o bi-cíclico opcionalmente sustituido, heterociclilo mono- o bi-cíclico opcionalmente sustituido, haloalquilo C₁₋₆, heterociclil(alquilo) opcionalmente sustituido, heteroaril(alquilo) opcionalmente sustituido, hidroxialquilo y perfluoroalquilo; R⁵ es selecciona independientemente de entre el grupo que consiste de H, alquilo C₁₋₆, arilo C₆₋₁₄ mono- o bi-cíclico, heteroarilo mono- o bi-cíclico, (aril)alquilo, (alcoxi)carbonilo, (alquil)amido, (alquil)amino, cicloalquilo mono- o bi-cíclico, heterociclilo mono- o bi-cíclico, alquilcarboxilo, heterociclil(alquilo), heteroaril(alquilo), hidroxialquilo, perfluoroalquilo, ariloxi, heteroariloxi, cicloalcoxi C₃₋₆ o heterocicliloxi que presenta 1 a 2 heteroátomos seleccionados de entre el grupo que consiste de O, S(O)ₙ y NR⁶; R⁶ se selecciona independientemente de entre el grupo que consiste de H, alquilo C₁₋₆, arilo C₆₋₁₄ mono- o bi-cíclico, heteroarilo mono- o bi-cíclico, (aril)alquilo, (alcoxi)carbonilo, (alquil)amido, (alquil)amino, cicloalquilo mono- o bi-cíclico, heterociclilo mono- o bi-cíclico, alquilcarboxilo, heterociclil(alquilo), heteroaril(alquilo), hidroxialquilo, perfluoroalquilo, ariloxi, heteroariloxi, cicloalcoxi C₃₋₆ o heterocicliloxi opcionalmente sustituido; y RC a RG se seleccionan independientemente de entre el grupo que consiste de H, halógeno, haloalquilo C₁₋₆, alcoxi C₁₋₆, heterociclo, alquilo C₁₋₆ opcionalmente sustituido, cicloalquilo C₃₋₈, CN, -O(arilo), alquinilo C₂₋₆, C₍O₎₋ₐₗqᵘⁱₗₒ C₁₋₆, -O-haloalquilo C₁₋₆ y arilo opcionalmente sustituido; o un isómero de los mismos, o un metabolito de los mismos, o una sal o éster farmacéuticamente aceptable de los mismos.
ARP150102666A 2014-08-21 2015-08-19 Derivados de iminonitrilo AR101589A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462040270P 2014-08-21 2014-08-21

Publications (1)

Publication Number Publication Date
AR101589A1 true AR101589A1 (es) 2016-12-28

Family

ID=54150480

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102666A AR101589A1 (es) 2014-08-21 2015-08-19 Derivados de iminonitrilo

Country Status (7)

Country Link
US (1) US20170273961A1 (es)
EP (1) EP3183235A1 (es)
JP (1) JP2017525765A (es)
CN (1) CN106795114A (es)
AR (1) AR101589A1 (es)
TW (1) TW201619133A (es)
WO (1) WO2016027241A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190003456A (ko) * 2016-04-01 2019-01-09 아프세스 게엠베하 & 씨오. 카게 면역치료의 항-종양 활성을 높이기 위한 중간엽 줄기세포
TW201815766A (zh) 2016-09-22 2018-05-01 美商普雷辛肯公司 用於ｉｄｏ及ｔｄｏ調節之化合物及方法以及其適應症
IL292677A (en) 2016-12-22 2022-07-01 Calithera Biosciences Inc Preparations and methods for inhibiting arginase activity
US11173145B2 (en) 2017-01-17 2021-11-16 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US11149011B2 (en) 2018-03-20 2021-10-19 Plexxikon Inc. Compounds and methods for IDO and TDO modulation, and indications therefor
US11046649B2 (en) 2018-07-17 2021-06-29 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
CN114835621A (zh) * 2021-01-30 2022-08-02 江苏天士力帝益药业有限公司 一种亚胺类ido抑制剂及其制备与用途
EP4052705A1 (en) 2021-03-05 2022-09-07 Universität Basel Vizerektorat Forschung Compositions for the treatment of ebv associated diseases or conditions
JP2024510949A (ja) 2021-03-05 2024-03-12 ウニヴェルシタット・バーゼル Ｅｂｖ関連疾患又は状態の治療用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095050A2 (en) * 2006-02-09 2007-08-23 Incyte Corporation N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase

Also Published As

Publication number Publication date
US20170273961A1 (en) 2017-09-28
CN106795114A (zh) 2017-05-31
TW201619133A (zh) 2016-06-01
WO2016027241A1 (en) 2016-02-25
EP3183235A1 (en) 2017-06-28
JP2017525765A (ja) 2017-09-07

Similar Documents

Publication Publication Date Title
AR101589A1 (es) Derivados de iminonitrilo
AR109349A1 (es) Compuestos y usos
AR104884A1 (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
AR100058A1 (es) DERIVADOS DE PIRIMIDIN-PIRAZINAS FUSIONADAS MODULADORES DE RORg
AR106605A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
AR097866A1 (es) Derivados de 4-azaindol
AR100809A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
EA201790407A1 (ru) Зонды для визуализации белка хантингтина
AR099379A1 (es) Compuestos tricíclicos como agentes antineoplásicos
AR101986A1 (es) Inhibidores de histona acetiltransferasas espirocíclicas (hat) y métodos para su uso
AR099400A1 (es) Compuesto heterocíclico fusionado
AR100808A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR100328A1 (es) Moduladores pirrolidina de gpr40
AR094762A1 (es) Compuestos de hexahidropirano[3,4-d][1,3]tiazin-2-amina sustituida con heteroarilo
AR105549A1 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
EA201790432A1 (ru) Зонды для визуализации белка хантингтина
EA201790400A1 (ru) Зонды для визуализации белка хантингтина
AR102957A1 (es) Combinaciones de compuestos activos
AR111252A1 (es) Compuestos de isoxazol carboxamida y usos de los mismos
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
AR104539A1 (es) Compuestos cíclicos
AR091534A1 (es) Derivados de sulfonamida y metodos de uso de los mismos para mejorar la farmacocinetica de un farmaco
AR099475A1 (es) Espiro-oxazolonas
AR101976A1 (es) Derivados de piridin-2(1h)-on quinolinona como inhibidores de isocitrato deshidrogenasa mutante

Legal Events

Date Code Title Description
FB Suspension of granting procedure